New Releases from NCBI BookshelfBurosumab for treating X-linked hypophosphataemia in adults.Burosumab for treating X-linked hypophosphataemia in adults.
Post Content
The cost of bringing a medical product to the U.S. market has been increasing and clinical trials constitute a large